Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy

Pediatric Cardiology

Volumn 26, Issue 5, 2005, Pages 558-564

  Fukuda, T ^a   Ishibashi, M ^b   Shinohara, T ^a   Miyake, T ^a   Kudoh, T ^a   Saga, T ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Collateral; Dipyridamole; Kawasaki disease; Scintigraphy; Technetium 99m tetrofosmin

Indexed keywords

DIPYRIDAMOLE; TETROFOSMIN TC 99M;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHILD; CLINICAL ARTICLE; COLLATERAL CIRCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DIPYRIDAMOLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 29544433889     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-004-0726-1     Document Type: Article

References (23)

1. American Heart Association Committee Report 1975 A reporting system on patients evaluated for coronary artery disease Circulation 51 7 40
2. MD Cerqueria NJ Weissman V Dilsizian 2002 Standard myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 539 542
3. M Cohen KP Rentrop 1986 Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary occlusion in human subjects: a prospective study Circulation 74 469 476
4. T Fukuda T Akagi M Ishibashi 1998 Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing Am Heart J 135 482 487
5. T Fukuda M Ishibashi T Yokoyama 2002 Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy J Nucl Cardiol 9 632 637
6. EV Garcia KV Train J Maddahi 1985 Quantification of rotational thallium-201 myocardial tomography J Nucl Med 26 17 26
7. C Greco G Tanzilli M Ciavolella 1996 Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability: radionuclide comparison before and after revascularization Coronary Artery Dis 7 877 884
8. S Hiraishi H Misawa N Takeda 2000 Transthoracic ultrasonic visualization of coronary aneurysm, stenosis, and occlusion in Kawasaki disease Heart 83 400 405
9. H Kato E Ichinose T Kawasaki 1986 Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases J Pediatr 108 923 927
10. H Kato E Ichinose F Yoshioka 1982 Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study Am J Cardiol 49 1758 1766
11. H Kato S Koike M Yamamoto Y Ito E Yano 1975 Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome J Pediatr 86 892 898
12. H Kato T Sugimura T Akagi 1996 Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients Circulation 94 1379 1385
13. SM Kegel TJ Dorsey M Rowen WF Taylor 1977 Cardiac death in mucocutaneous lymph node syndrome Am J Cardiol 40 282 286
14. 201Tl myocardial tomography Circulation 80 615 624
15. C Kondo T Nakanishi 1993 Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease Am J Cardiol 71 681 685
16. JW Newburger M Takahashi AS Beiser 1991 A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1633 1639
17. JW Newburger M Takahashi JC Burns 1986 The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 341 347
18. N Sato T Sugimura T Akagi 1999 Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness Pediatr Int 41 1 7
19. A Suzuki T Kamiya Y Ono 1993 Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease Am J Cardiol 71 1169 1173
20. K Takahashi A Hirota S Naoe 1993 A morphological study of intimal thickening in sequelae of coronary arterial lesions of Kawasaki disease (1) J Jpn Coll Angiol 31 17 25
21. N Tamaki N Takahashi M Kawamoto 1994 Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease J Nucl Med 35 594 600
22. K Tatara S Kusakawa K Itoh 1991 Collateral circulation in Kawasaki disease with coronary occlusion or severe stenosis Am Heart J 121 797 802
23. K Tatara M Murata K Itoh N Kazuma C Kondo 1996 Management of severe sequelae of Kawasaki disease Am Heart J 131 576 581